Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
05/2008
05/29/2008WO2008045564A3 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
05/29/2008US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics
05/29/2008US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors
05/29/2008US20080124572 A carbazole skeleton to which a diarylamino group bonds via a bonding group as a hole transporting material or a hole injecting material has an enhanced efficiency of light emission and is highly practical; enhances yield in device, improves lifetime
05/29/2008US20080124571 Obtaining long-life blue light emission with high luminous efficiency
05/29/2008CA2670143A1 Pyrimidines and their use as cxcr2 receptor antagonists
05/29/2008CA2669083A1 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives as antitumor agents
05/29/2008CA2668578A1 Pyridazin-4-ylmethyl-sulfonamides used as fungicides
05/29/2008CA2668567A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods
05/28/2008EP1924578A2 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
05/28/2008EP1924572A1 Regioselective process for preparing benzimidazole thiophenes
05/28/2008EP1924568A1 Quinazoline derivatives useful in cancer treatment
05/28/2008EP1924567A2 Process for the preparation of pyrimidinedione derivatives
05/28/2008EP1924561A2 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
05/28/2008EP1924560A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
05/28/2008EP1924553A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
05/28/2008EP1846381B1 HETEROARYLACETAMIDES AS FACTOR Xa INHIBITORS
05/28/2008EP1577294A4 S-substituted n-1- (hetero)aryl alkyl-n - (hetero)aryl alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1- (hetero )aryl alkyl-n - (hetero)aryl alkylysothiocarbamides,a pharmaceutical compound and curing method
05/28/2008EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
05/28/2008EP1404668B1 Variolin derivatives and their use as antitumor agents
05/28/2008EP1218360B1 Triazine kinase inhibitors
05/28/2008CN101189225A Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity
05/28/2008CN101189221A AMPA receptor potentiators
05/28/2008CN101189214A Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides
05/28/2008CN101189210A Sulfonamide derivatives useful as liver carnitine palmitoyl transferase (L-CPTl) inhibitors
05/28/2008CN101186605A 2-vinyl-8-hydroxyquinoline derivative, preparation method and application thereof
05/27/2008US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/27/2008US7378524 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors.
05/27/2008US7378522 Such as 6-(4-Acetamidophenoxy)-5-(N-benzyl-N-methylaminomethyl)-1-(2',6'-difluorobenzyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid-ethyl ester; rapid effectiveness, bioavailability; low cost, simple synthesis
05/27/2008US7378438 Asthma; side effect reduction; converting SH groups to SNO groups of N-benzylphthalimide usingHCl and NaNO2; epoxide or thioepoxid of N-benzylphthalimide; amination; 5-{2-[(1-Yloxyl-2,2,5,5-tetramethyl-pyrrolidin-3-ylmethyl)-amino]-1-S-nitroso-ethyl}-1,1,3,3-tetramethylisoindolin-2-yloxyl, hydrochloride
05/27/2008US7378431 Amide derivatives as NMDA receptor antagonists
05/27/2008US7378413 2-amino-3-(alkyl)-pyrimidone derivatives
05/27/2008US7378375 Substituted pyridine herbicides
05/22/2008WO2008061236A2 Sulfoximines as kinase inhibitors
05/22/2008WO2008061029A1 Aryl sulfonamide derivatives and methods of their use
05/22/2008WO2008060998A1 Indole sulfonamides as sfrp-1 modulators
05/22/2008WO2008060190A2 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof
05/22/2008WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
05/22/2008WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
05/22/2008WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
05/22/2008WO2008059854A1 Piperidine derivatives or salts thereof
05/22/2008WO2008059339A2 Isoquinoline derivatives as vanilloid receptor modulators
05/22/2008WO2008059239A1 Novel compounds 514
05/22/2008WO2008059042A1 2-carboxy thiophene derivatives as anti viral agents
05/22/2008WO2008058402A1 Compounds and methods for treating protein folding disorders
05/22/2008WO2008058393A1 Thiophene analogues for the treatment or prevention of flavivirus infections
05/22/2008WO2008058341A1 Inhibitors of kinase activity
05/22/2008WO2008011392A3 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation
05/22/2008US20080119526 Ep2 receptor agonists
05/22/2008US20080119524 Treating conditions related to Ras or Ras-like protein prenylation such as cancer, restenosis, psoriasis, endometriosis, atherosclerosis, ischemia, myocardial ischemic disorders; amide-functional pyrazole compounds containing 2,2-dimethylcyclobutan-1,3-ylene moiety
05/22/2008US20080119504 aporphine 10- and 11-mono-esters and 10,11-asymmetric di-esters; dopaminergic agonist; Parkinson's disease, hemicrania, restless leg syndrome, sexual dysfunction, hyperprolactemia and psychotic disorders
05/22/2008US20080119490 Viral Polymerase Inhibitors
05/22/2008US20080119488 Modulators Of Nuclear Receptors
05/22/2008US20080119487 Novel non-imidazole compounds
05/22/2008US20080119477 N-Biaryl and N-Arylheteroaryl Piperazine Derivatives as Modulators of the 5Ht2c Receptor Useful For the Treatment of Disorders Related Thereto
05/22/2008US20080119464 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis
05/22/2008CA2701959A1 Inhibitors of kinase activity
05/22/2008CA2670260A1 Thiophene analogues for the treatment or prevention of flavivirus infections
05/22/2008CA2669704A1 Sulfoximines as kinase inhibitors
05/22/2008CA2669635A1 Piperidine derivative or salt thereof
05/22/2008CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
05/22/2008CA2668744A1 Compounds and methods for treating protein folding disorders
05/22/2008CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
05/22/2008CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
05/21/2008EP1923390A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
05/21/2008EP1922316A1 Benzimidazole thiophene compounds as plk modulators
05/21/2008EP1922313A1 Pyrazine derivatives useful as adenosine receptor antagonists
05/21/2008EP1737838B1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
05/21/2008EP1603893B1 Ep4 receptor antagonists
05/21/2008EP1562595B1 Diaryl ethers as opioid receptor antagonists
05/21/2008EP1183253B1 C7 ester substituted taxanes as antitumor agents
05/21/2008CN101184728A Peptide deformylase (PDF) inhibitors 4
05/21/2008CN101182307A Bromine difluoro methyl substituted pyrazole derivatives
05/21/2008CN100389113C Nitrogenous heterocyclic compound and medicine containing the same
05/21/2008CN100389109C Non-nucleoside reverse transcriptase inhibitors
05/20/2008US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods
05/20/2008US7375222 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder
05/20/2008US7375219 neuronal nitric oxide synthase (nNOS) isoform inhibitors; 2-ethyl-1-(1H-indol-5-yl)-isothiourea; neurogenerative disorders, stroke, reperfusion injury, head trauma, migraine headache, neuropathic pain, drug abuse, hyperalgesia
05/20/2008US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators
05/20/2008US7375119 Novel inhibitor of FXa that can be administered orally; less toxic; enzyme selectivity; high bioavailability; treatment of diseases caused by thrombi or emboli; N-(5-Chloropyridin-2-yl)-5-methoxy-2-({[trans-4-(3-oxomorpholin-4-yl)cyclohexyl]carbonyl}amino)benzamide
05/20/2008US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
05/20/2008US7375114 minimal side effects, selectivity, potency, pharmacokinetics, duration of action; CNS disorders like cognitive, behavioral, mood, autonomic functions; 1-isopropyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-acetylamino-2-hydroxypropyl]-8-azabicyclo[3.2.1]oct-3-yl}amide
05/20/2008US7375102 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide
05/20/2008US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis
05/20/2008US7375099 Malonamide derivatives
05/20/2008CA2432223C Pyrazole compounds useful as protein kinase inhibitors
05/20/2008CA2415681C Pyrrolidine derivatives
05/20/2008CA2298461C Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
05/20/2008CA2268886C Aminothiophenecarboxamides
05/15/2008WO2008057873A2 Inhibitors of hepatitis c virus
05/15/2008WO2008057871A2 Inhibitors of hepatitis c virus
05/15/2008WO2008057857A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
05/15/2008WO2008057856A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
05/15/2008WO2008057681A2 Thiophene compounds
05/15/2008WO2008057585A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
05/15/2008WO2008057497A2 Small organic molecule regulators of cell proliferation
05/15/2008WO2008057469A1 Small organic molecule regulators of cell proliferation
05/15/2008WO2008057468A1 Small organic molecule regulators of cell proliferation
05/15/2008WO2008057254A2 Tricyclic compounds as matrix metalloproteinase inhibitors
05/15/2008WO2008057131A1 Heteroaryl (substituted) alkyl n-substituted sulfoximines as insecticides
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 523